Background: Metalworking fluids (MWF) are the most important cause of hand dermatitis in the metal industry. The substitution of noxious products by less aggressive MWFs is therefore an important measure to reduce the incidence of hand eczema in this type of industry. In order to do so, producers and suppliers have to evaluate the skin risk of such products by predictive allergenicity and irritancy testing. Objective: The aim of the study is to evaluate if predictive testing is performed in MWF products that are currently offered in the Swiss market and what kind of tests are applied. Methods: A questionnaire was sent to 11 Swiss MWF suppliers in order to collect information on the actual practice of skin risk testing. Results: Nine of 11 suppliers returned the questionnaire. Five suppliers report some kind of allergenicity testing in some of the products. Seven companies test for irritancy by a single application method, but only two perform cumulative irritancy testing in some products. The methods of testing (animal, human, field studies) vary greatly among the different companies. Conclusion: It is concluded that the practice of predictive testing for sensitization and irritancy of MWF is unsatisfactory and does not allow the user to compare products based on their skin risk. Occupational dermatologists should strive for standardization of MWF testing including so far scarcely performed repeated insult tests.

Keywords:
Metalworking fluids, Skin risk assessment, Contact dermatitis
This content is only available via PDF.
© 1996 S. Karger AG, Basel
1996
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.